We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+7.08%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$809M
AUM Growth
+$404M
Cap. Flow
+$13B
Cap. Flow %
1,601.81%
Top 10 Hldgs %
38.43%
Holding
159
New
60
Increased
32
Reduced
34
Closed
31

Top Buys

Rank Stock Value
1
ISRL
Isramco Inc
ISRL
+$12.6B
2
AGN
Allergan plc
AGN
+$27.3M
3
ABBV icon
AbbVie
ABBV
+$22.4M
4
SHPG
Shire pic
SHPG
+$19.6M
5
PFE icon
Pfizer
PFE
+$18.3M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$12.7M
2
GSK icon
GSK
GSK
+$9.95M
3
BIIB icon
Biogen
BIIB
+$6.94M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$5.6M
5
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
+$5.12M

Sector Composition

Rank Sector Weight
1 Healthcare 57.07%
2 Technology 4.45%
3 Energy 3.1%
4 Industrials 2.68%
5 Materials 1.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGIO icon
126
Agios Pharmaceuticals
AGIO
$1.79B
$25K ﹤0.01%
405
-24,595
-98% -$1.06M
AN icon
127
AutoNation
AN
$7.11B
– –
-52,600
Closed -$3.14M
ARWR icon
128
Arrowhead Research
ARWR
$11.9B
– –
-100,000
Closed -$1.43M
BIIB icon
129
Biogen
BIIB
$30B
– –
-22,000
Closed -$6.94M
BKNG icon
130
Booking.com
BKNG
$149B
– –
-48,300
Closed -$2.32M
CSTE icon
131
Caesarstone
CSTE
$72.3M
– –
-59,600
Closed -$2.92M
GILD icon
132
Gilead Sciences
GILD
$162B
– –
-50,000
Closed -$4.9M
GLMD icon
133
Galmed Pharmaceuticals
GLMD
$5.13M
– –
-944
Closed -$1.66M
INSM icon
134
CALL
Insmed
INSM
$21.4B
– –
-1,000
Closed -$293K
INSM icon
135
Insmed
INSM
$21.4B
– –
-79,400
Closed -$1.59M
NGNE icon
136
Neurogene
NGNE
$656M
– –
-9,500
Closed -$1.78M
PAG icon
137
Penske Automotive Group
PAG
$14.3B
– –
-29,327
Closed -$1.45M
PHIO icon
138
Phio Pharmaceuticals
PHIO
$11.8M
– –
0
– -$531K
SAH icon
139
Sonic Automotive
SAH
$2.9B
– –
-50,000
Closed -$1.33M
SNY icon
140
Sanofi
SNY
$103B
– –
-120,000
Closed -$12.7M
SPY icon
141
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$790B
– –
-1,500
Closed -$338K
TEVA icon
142
PUT
Teva Pharmaceuticals
TEVA
$40.8B
– –
-1,000
Closed -$80K
TGTX icon
143
TG Therapeutics
TGTX
$7.96B
– –
-60,000
Closed -$563K
VRTX icon
144
CALL
Vertex Pharmaceuticals
VRTX
$121B
– –
-1,000
Closed -$1.91M
VRTX icon
145
PUT
Vertex Pharmaceuticals
VRTX
$121B
– –
-1,500
Closed -$13K
WBA
146
DELISTED
Walgreens Boots Alliance
WBA
– –
-60,993
Closed -$4.52M
ITCI
147
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-94,300
Closed -$1.59M
PLXP
148
DELISTED
PLx Pharma Inc. Common Stock
PLXP
– –
-11,800
Closed -$916K
AMPE
149
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
– –
-1,040
Closed -$2.6M
ACHN
150
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-150,000
Closed -$1.14M
3 4 5
6
7

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q3 2014 Portfolio in Review

As of Q3 2014, Sphera Funds Management held 159 positions worth $809M, up 99% from $406M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Sphera Funds Management deployed $13B of net new capital in Q3 2014, opening 60 new positions and adding to 32 existing holdings. Its largest new stake was Isramco Inc: 103,111,944 shares worth $22.1M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 74% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was GSK, an estimated $9.95M trimmed.

  • Sphera Funds Management's largest Q3 2014 buy was Isramco Inc: 103,111,944 shares worth $22.1M.
  • Sphera Funds Management added most to Shire pic in Q3 2014, an estimated $19.6M increase.
  • Sphera Funds Management's biggest Q3 2014 reduction was GSK, cutting an estimated $9.95M.
  • Sphera Funds Management fully exited Sanofi in Q3 2014, selling an estimated $12.7M.
  • Sphera Funds Management's ten largest holdings make up 38% of its $809M portfolio in Q3 2014.
  • Sphera Funds Management opened 60 new positions and closed 31 in Q3 2014.
  • Sphera Funds Management's portfolio value rose 99% quarter-over-quarter to $809M.

Based on Sphera Funds Management's 13F filing for Q3 2014, filed 13 Nov 2014.